Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal

Voyager Therapeutics, a developer of gene therapies for neurological disorders, is collaborating with drug maker AbbVie on treatments for diseases resulting from the build-up of damaging proteins in the brain, as in Alzheimer’s disease. . . . → Read More: Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal

RNA Vaccine Shows Promise with Infant Viral Diseases

A vaccine using synthetic RNA, with protein instructions transcribed from one’s genetic code, is shown in tests with lab animals to protect against infections from cytomegalovirus, a virus affecting infants and transplant recipients. . . . → Read More: RNA Vaccine Shows Promise with Infant Viral Diseases

Embracing Technology for Better Business Efficiency

Finding technology that works to make your office more efficient in all aspects, from trading to productivity to saving money is essential towards achieving further growth in your company. . . . → Read More: Embracing Technology for Better Business Efficiency

Scenes from the AAAS Annual Meeting

There’s more going on at the AAAS meeting than papers and presentations, including Family Science Days, always a big hit with kids of all ages. . . . → Read More: Scenes from the AAAS Annual Meeting

Gut Tissue From Stem Cells Simulated on Organ Chips

Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients. . . . → Read More: Gut Tissue From Stem Cells Simulated on Organ Chips

Alexa, How Will Amazon Echo Affect My Business?

What on earth is the IoT, you ask? Well, it’s a digital presence connecting everyday household items and the internet. . . . → Read More: Alexa, How Will Amazon Echo Affect My Business?

NIH Exec: Research Offers Opioid Crisis Solutions

The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths. . . . → Read More: NIH Exec: Research Offers Opioid Crisis Solutions

Cancer Analytics Company Acquired in $1.9B Deal

The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal

Going to Austin, City with No Limits

Science & Enterprise is headed to Austin, Texas to cover the annual meeting of American Association for the Advancement of Science, or AAAS, and we will report from the meeting from Friday through Sunday. . . . → Read More: Going to Austin, City with No Limits

FDA Clears First Blood Test for Concussions

The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury. . . . → Read More: FDA Clears First Blood Test for Concussions